The potential impact of a prophylactic vaccine for Ebola in Sierra Leone

The 2014 outbreak of Ebola virus disease (EVD) in West Africa was multinational and of an unprecedented scale primarily affecting the countries of Guinea, Liberia, and Sierra Leone. One of the qualities that makes EVD of high public concern is its potential for extremely high mortality rates (up to...

Full description

Saved in:
Bibliographic Details
Main Authors: Erin N. Bodine, Connor Cook, Mikayla Shorten
Format: Article
Language:English
Published: AIMS Press 2018-03-01
Series:Mathematical Biosciences and Engineering
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/mbe.2018015
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590072359157760
author Erin N. Bodine
Connor Cook
Mikayla Shorten
author_facet Erin N. Bodine
Connor Cook
Mikayla Shorten
author_sort Erin N. Bodine
collection DOAJ
description The 2014 outbreak of Ebola virus disease (EVD) in West Africa was multinational and of an unprecedented scale primarily affecting the countries of Guinea, Liberia, and Sierra Leone. One of the qualities that makes EVD of high public concern is its potential for extremely high mortality rates (up to 90%). A prophylactic vaccine for ebolavirus (rVSV-ZEBOV) has been developed, and clinical trials show near-perfect efficacy. We have developed an ordinary differential equations model that simulates an EVD epidemic and takes into account (1) transmission through contact with infectious EVD individuals and deceased EVD bodies, (2) the heterogeneity of the risk of becoming infected with EVD, and (3) the increased survival rate of infected EVD patients due to greater access to trained healthcare providers. Using fitted parameter values that closely simulate the dynamics of the 2014 outbreak in Sierra Leone, we utilize our model to predict the potential impact of a prophylactic vaccine for the ebolavirus using various vaccination strategies including ring vaccination. Our results show that an rVSV-ZEBOV vaccination coverage as low as 40% in the general population and 95% in healthcare workers will prevent another catastrophic outbreak like the 2014 outbreak from occurring.
format Article
id doaj-art-a700e728377649608c51455bea6b1d57
institution Kabale University
issn 1551-0018
language English
publishDate 2018-03-01
publisher AIMS Press
record_format Article
series Mathematical Biosciences and Engineering
spelling doaj-art-a700e728377649608c51455bea6b1d572025-01-24T02:40:44ZengAIMS PressMathematical Biosciences and Engineering1551-00182018-03-0115233735910.3934/mbe.2018015The potential impact of a prophylactic vaccine for Ebola in Sierra LeoneErin N. Bodine0Connor Cook1Mikayla Shorten2Rhodes College, Department of Mathematics & Computer Science, 2000 N. Parkway, Memphis, TN 38112, USARhodes College, Department of Mathematics & Computer Science, 2000 N. Parkway, Memphis, TN 38112, USARhodes College, Department of Mathematics & Computer Science, 2000 N. Parkway, Memphis, TN 38112, USAThe 2014 outbreak of Ebola virus disease (EVD) in West Africa was multinational and of an unprecedented scale primarily affecting the countries of Guinea, Liberia, and Sierra Leone. One of the qualities that makes EVD of high public concern is its potential for extremely high mortality rates (up to 90%). A prophylactic vaccine for ebolavirus (rVSV-ZEBOV) has been developed, and clinical trials show near-perfect efficacy. We have developed an ordinary differential equations model that simulates an EVD epidemic and takes into account (1) transmission through contact with infectious EVD individuals and deceased EVD bodies, (2) the heterogeneity of the risk of becoming infected with EVD, and (3) the increased survival rate of infected EVD patients due to greater access to trained healthcare providers. Using fitted parameter values that closely simulate the dynamics of the 2014 outbreak in Sierra Leone, we utilize our model to predict the potential impact of a prophylactic vaccine for the ebolavirus using various vaccination strategies including ring vaccination. Our results show that an rVSV-ZEBOV vaccination coverage as low as 40% in the general population and 95% in healthcare workers will prevent another catastrophic outbreak like the 2014 outbreak from occurring.https://www.aimspress.com/article/doi/10.3934/mbe.2018015ebolavirusprophylactic vaccinevaccine coveragering vaccinationordinary differential equationsepidemiologypopulation dynamicssierra leone
spellingShingle Erin N. Bodine
Connor Cook
Mikayla Shorten
The potential impact of a prophylactic vaccine for Ebola in Sierra Leone
Mathematical Biosciences and Engineering
ebolavirus
prophylactic vaccine
vaccine coverage
ring vaccination
ordinary differential equations
epidemiology
population dynamics
sierra leone
title The potential impact of a prophylactic vaccine for Ebola in Sierra Leone
title_full The potential impact of a prophylactic vaccine for Ebola in Sierra Leone
title_fullStr The potential impact of a prophylactic vaccine for Ebola in Sierra Leone
title_full_unstemmed The potential impact of a prophylactic vaccine for Ebola in Sierra Leone
title_short The potential impact of a prophylactic vaccine for Ebola in Sierra Leone
title_sort potential impact of a prophylactic vaccine for ebola in sierra leone
topic ebolavirus
prophylactic vaccine
vaccine coverage
ring vaccination
ordinary differential equations
epidemiology
population dynamics
sierra leone
url https://www.aimspress.com/article/doi/10.3934/mbe.2018015
work_keys_str_mv AT erinnbodine thepotentialimpactofaprophylacticvaccineforebolainsierraleone
AT connorcook thepotentialimpactofaprophylacticvaccineforebolainsierraleone
AT mikaylashorten thepotentialimpactofaprophylacticvaccineforebolainsierraleone
AT erinnbodine potentialimpactofaprophylacticvaccineforebolainsierraleone
AT connorcook potentialimpactofaprophylacticvaccineforebolainsierraleone
AT mikaylashorten potentialimpactofaprophylacticvaccineforebolainsierraleone